Abstract: This account describes our syntheses and conformational analyses of the bicyclic nucleoside analogues, 3'-O,4'-C-methyleneribonucleosides (4-BC), 31-amino-3'.-deoxy-3'-O,4'-C-methyleneribonucleosides (aza 4-BC), 2'-O,4'-C-methyleneribonucleosides (5-BC), and 3'-amino-and 31-azido-31deoxy-2'-O,4'-C-methyleneribonucleosides (aza 5-BC). The nucleoside analogues (4-BC and 5-BC) were effectively introduced into oligonucleotides by using a DNA synthesizer. Furthermore, unprecedented hybridizing ability towards complementary RNA and DNA, potent triplex forming ability, and sufficient enzymatic stability of these modified oligonucleotides were also confirmed. From these studies, we believe that these conformationally restrained nucleoside analogues are good candidates for practical antisense/antigene molecules.
Introduction
Inhibition of protein biosynthesis by the sequence-specific binding of an oligonucleotide to single-stranded (ss) RNA or double-stranded (ds) DNA target ("antisense" and "antigene" strategies, respectively) has developed into an important novel approach in modern drug design (ref. 1). These "antisense" and "antigene" methodologies consist of blocking the stream of Central Dogma (DNARNAprotein) as illustrated in Fig. 1 . Due to the insufficient metabolic stability of natural DNA and RNA under physiological conditions, the successful implementation of such oligonucleotide-based drug design strategies depends on the availability of chemically modified oligonucleotides: these molecules are required to have a high binding ability with their complementary target nucleic acids in a sequence-specific manner as well as an increased resistance to nucleolytic degradation. During the last decade, various kinds of chemically modified nucleoside analogues have been prepared and incorporated into oligonucleotides, and their properties (nuclease resistance, RNA-(or DNA-) binding ability, etc.) have been investigated in some detail ( Fig. 2) (ref. 2) . Just recently, the first antisense drug for CMV retinitis using a PS-oligonucleotide was approved by FDA. ring system, with the tetrahydrofuran part conformationally restrained by the fused oxetane ring. From the molecular modeling study (PM3), the 4-BC type nucleoside analogues 1 were found to predominantly exist in an S-conformation (Fig. 5) .
The synthetic route to the target nucleoside analogues 1 from uridine (uridine route) is shown in Scheme 1. The starting material 2 was obtained from uridine via a several-step sequence (ref. 15). Selective tosylation of the diastereotopic hydroxymethyl group in 2 afforded monotosylate 3 along 
2'-0,4'-C-Methyleneribonucleosides (5-BC Type)
It is well known that the duplex formation of the preorganized oligonucleotides with complementary DNA and RNA is entropically favorable (ref. 5). In addition, for the reason that the Aform RNA duplex possesses an N-type sugar conformation while the B-form DNA duplex has an 5-conformation (ref. 4), the nucleoside analogues with a rigid N-conformation are readily expected to enhance the hybridization ability towards complementary RNA when they are introduced into oligonucleotides.
Therefore, other conformationally restricted nucleoside analogues (5-BC type), 2'-O,4'-Cmethyleneribonucleosides, which were easily assumed to have a typical N-conformation by considering their rigid bicyclo[2.2.1]heptane ring system, were synthesized via the uridine route (Scheme 3) (ref. 9) . Because the reaction of 6 (5'-O-DMTr derivative of 5) under the alkaline conditions was found to give exclusively the oxetane product 7 (Scheme 1), an alternative route should Just after our publication of the synthesis of 22 and 24 (ref. 9), Wengel and co-workers reported the same compound via the glucose route as illustrated in Fig. 6 (ref. 20) . Independently, we have also achieved the synthesis of 22 (B = T, ABZ and GiBu) in a similar manner (ref. 21).
Aza 4-BC and Aza 5-BC Type Nucleoside Analogues
The azetidine derivative (aza 4-BC) is one of the isosters of the oxetane derivative (4-BC), and is potentially capable of introducing some functional groups at the 3'-nitrogen atom, such as a fluorescent or a chemiluminescent probe, an intercalator, and DNA scissors. Furthermore, the conformational difference between the oxetane derivative (4-BC) and the azetidine derivative (aza 4-BC) is of great interest. The synthesis of the aza 4-BC type nucleoside analogue 25 was effectively achieved via the glucose route by using 3-azido derivative 26 (ref. 22) as the starting material (Scheme 3) (ref. 23 ). An azido group in 27 was reduced and the resulting aminoalcohol was tosylated to give 28. Treatment of 28 with sodium hydride effectively caused an azetidine ring formation, and subsequent deprotection at azetidine nitrogen gave 29. After benzyloxycarbonylation of 29, acetolysis was performed to give 30. The desired compound 25 (aza 4-BC) was obtained by a coupling reaction with silylated thymine and a following deprotection of 2'-and 5'-hydroxy groups.
In addition, the aza 5-BC type nucleoside analogues, 3'-azido-3'-deoxy-2'-0,4'-C-methylene-5-methyluridine 31 and its 3'-amino congener 32 were also synthesized from 27 (ref. 24) . Tosylation and acetolysis of 27 gave the diacetate 33, which was coupled with silylated thymine in the presence of SnCl4 to give 3'-azido-3'-deoxythymidine derivative 34. Treatment of 34 with potassium carbonate 
Conformational Analysis of the Nucleoside Analogues
In general, a sugar moiety in natural and modified nucleosides exists in a dynamic equilibrium between N-and S-conformations (Fig. 2) . The conformation of nucleosides in a solution is easily estimated from coupling constants between the ribose ring hydrogens in the 1H NMR spectra (ref. 26). Since the bicyclic nucleoside analogues have no 4'-hydrogen atom, the simplest equation was adopted for calculation to obtain the percentage of S-conformation (Equation 1) (ref. 8, 26 ).
(Equation 1)
As summarized in Table 1 , all of the 4-BC and aza 4-BC type nucleoside analogues show relatively large Jr2' values, which means that these nucleosides have predominantly S-conformation. On the other hand, the 5-BC and aza 5-BC type nucleoside analogues exhibit all singlet signals for C C2'-and C3'-hydrogens. The result reveals that the 5-BC type nucleoside analogues have exclusively N-conformation.
An X-ray crystallographic analysis of the 4-BC type nucleoside analogue 1 (B T) and the 5-BC type analogue 22 (B = U) was performed (Fig. 7) and it was found that 1 is in an S-conformation where the sugar pseudorotation phase angle (P) was 136.3 °, while 22 is in an N-conformation where P was 17.4 °. These data thoroughly satisfy the results from 1H NMR experiments. 4-BC nucleoside analogue 1 (B=T) 5-BC nucleoside analogue 22 (B=U)
Incorporation of the. Nucleoside Analogues into Oligonucleotides
As shown in Scheme 5, the phosphoramidite building blocks 33 and 34 were prepared from the corresponding 5'-O-dimethoxytrityl derivatives by the usual method (ref. 10, 11) . The modified oligonucleotides were successfully synthesized using a standard phosphoramidite protocol on a DNA synthesizer. In addition, the 5-BC type phosphoramidites 34 were treated with triazole, POC13 and Et3N to yield the corresponding 4-triazolo derivatives 35, which can be converted into the cytidine or 5-methylcytidine derivatives by treatment with conc. ammonia after oligonucleotide synthesis (ref. 27 ). The purity of the obtained oligonucleotides was verified using analytical HPLC and the composition was determined by MALDI-TOF-MS spectrometry. Table 1 Conformational analysis of nucleoside analogues using 1H NMR spectra (in CD3OD). The hybridizing ability of the modified oligonucleotides to the complementary DNA or RNA in 10 mM sodium phosphate buffer (pH 7.2) and 100 mM sodium chloride was assessed by analysis of the UV melting curve. The melting temperatures (Tm) for the modified oligonucleotides are summarized in Tables 2 and 3 
Furthermore, triplex-forming ability of the oligonucleotides containing the 5-BC type nucleoside analogues was also studied by Tm measurements (Table 4) and DNase I footprinting assay (Fig. 8) (ref. 28) . The natural oligonucleotide can not bind to the target duplex at both pH 6.6 and 7.2 (entry 1), while the oligonucleotide in which cytidine is replaced by 5-methylcytidine is able to form the triplex at pH 6.6 (entry 2). Although the fully modified oligonucleotides (except for the 3'-end) exhibit no triplex-forming ability at both pH 6.6 and 7.2 (entries 10 and 11), the partially modified oligonucleotides are shown to have significantly enhanced triplex-forming ability (entries 3-9); indeed, the modified oligonucleotides containing a 5-methylcytosine moiety showed remarkable binding affinity towards the target duplex even under neutral conditions (entries 5, 7 and 9).
Enzymatic Stability of the Modified Oligonucleotides
The sufficient stability against nucleolytic degradation is a prerequisite for a modified oligonucleotide to be employed for the antisense/antigene application. To examine the enzymatic stability of the modified oligonucleotides containing the 4-BC or 5-BC type nucleoside analogues, we selected one of the most representative 3'-exonucleases, snake venom phosphodiesterase (SVPDE). The 5'-labeled (32P) natural and modified (5-BC type) oligonucleotides were treated with SVPDE, and then analyzed by denaturing polyacrylamide gel electrophoresis (PAGE) (Fig. 9) . The natural oligonucleotide was rapidly digested to give many bands derived from the degraded products, while the partially modified oligonucleotide (5-BC type) was little affected and mostly maintained its full length for at least 8 h. The 4-BC type modification was also found to enhance the enzymatic stability (ref. 11).
Conclusion
We have demonstrated the effective syntheses of the conformationally restrained nucleoside analogues (4-BC, 5-BC, aza 4-BC and aza 5-BC) via a uridine route or a glucose route. The conformational analysis of these compounds was also studied by using 1H NMR and X-ray crystallographic data to reveal that the 4-BC type nucleoside analogues exist predominantly in an S-conformation, while the 5-BC type nucleoside analogues are exclusively locked in an N-conformation. From the facts that oligonucleotides containing the nucleoside modifications show extraordinary strong binding affinity towards ssRNA (duplex formation) and/or dsDNA (triplex formation) and satisfactory nucleaseresistance, these conformationally restrained nucleosides could serve as potential components for practical antisense/antigene methodologies not only in clinical or diagnostic uses, but also in various biological researches. 
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